Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood test can accurately diagnose heart failure in emergency patients

11.04.2005


Measuring protein level provides accurate assessment for patients with shortness of breath

A new blood test that measures a particular marker of cardiac distress can markedly improve the ability to diagnose or exclude congestive heart failure in patients with shortness of breath who come to hospital emergency departments. The report from researchers at Massachusetts General Hospital (MGH) finds that measuring levels of a protein called NT-proBNP was significantly better at identifying heart failure than was standard clinical evaluation. The report will appear in the April 15 issue of the American Journal of Cardiology and has been released online prior to print publication.

"We found that testing with the NT-proBNP assay was an extremely accurate way to identify or exclude heart failure in patients with shortness of breath," says James Januzzi Jr., MD, of the MGH Cardiology Division, the paper’s lead author. "Importantly, we also found that the very best results came from combining the results of this very sensitive and specific blood test with the logic and wisdom of a good emergency physician, which gave the optimal balance between biologic data and clinical judgement."



Congestive heart failure, which occurs when an impaired heart muscle cannot pump blood efficiently, is a growing health problem and major cause of cardiac death. The diagnosis of heart failure may be difficult to make because its typical symptoms can overlap with those of other conditions. Missing a heart failure diagnosis can put patients at high risk of serious problems, including death, but overdiagnosis may lead patients to receive unnecessary treatment.

"To date, the way physicians have traditionally evaluated potential heart failure patients has been rather random, with some receiving a physical examination and medical history while others also get expensive and time-consuming procedures," Januzzi says. "Having a widely-available, accurate, and cost-effective diagnostic method would be of extraordinary value."

Proteins called natriuretic peptides are produced when the cardiac muscle is under stress. The role of testing for these proteins in several forms of cardiovascular disease has been the subject of intense recent study. In 2002, the newest generation of natriuretic peptide assays became available, and soon thereafter the current investigation – called the PRIDE study – was launched to determine the usefulness of a test for NT-proBNP in evaluating emergency patients. At the time of its launch, the PRIDE study was the first prospective American trial of NT-proBNP and the largest such study to study the test in patients with shortness of breath.

About 600 patients who came to the MGH Emergency Department with shortness of breath were enrolled in the study. In addition to standard evaluation of symptoms, a blood sample was drawn for NT-proBNP measurement. After the emergency assessment was completed, the attending physicians were asked to estimate the likelihood that the patients’ symptoms were caused by heart failure, based on all available information except the NT-proBNP assay. For patients admitted to the hospital, the entire record of their stay was included in the study data. Sixty days after the original emergency visit, the researchers followed up with each patient, contacting them personally and reviewing their records to identify any subsequent clinical events. Participation in the study in no way changed the care or treatment the patients received.

To determine the diagnoses for this study, cardiologists not involved in the patients’ care reviewed all the participants’ relevant hospital records from the initial emergency visit through the 60-day follow up. In assigning the final diagnosis – either acute heart failure or some other cause for shortness of breath – these physicians also did not have access to the NT-proBNP results.

When they reviewed NT-proBNP levels, the researchers found that the protein’s concentrations were significantly higher in patients eventually diagnosed with heart failure and highest in those with most severe symptoms. For identifying heart failure in these emergency patients, the test alone was significantly more accurate than was the physicians’ original likelihood assessment, but a combination of NT-proBNP levels and physician judgement produced the most accurate method of diagnosis.

"We also identified specific NT-proBNP levels above which the diagnosis of heart failure is clear and below which the symptoms are definitely not cardiac-related," Januzzi says. "So we’ve shown that this test not only can confidently exclude the presence of congestive heart failure, which other studies have examined, but can confirm that diagnosis as well. NT-proBNP performed exceptionally well and confirms the value of the natriuretic peptide class of cardiac biomarkers as a whole. We believe NT-proBNP testing should now become a routine component of evaluation for patients with shortness of breath in emergency department settings." Januzzi is an assistant professor of Medicine at Harvard Medical School.

Co-authors of the study – all from the MGH – are Carlos Camargo, MD, PhD; Saif Anwaruddin, MD; Aaron Baggish, MD; Annabel Chen, MD; Daniel Krauser, MD; Roderick Tung, MD; Renee Cameron, MS; Tobias Nagurney, MD; Claudia Chae, MD, MPH; Donald Lloyd-Jones, MD, ScM; David Brown, MD; Stacy Foran-Melanson, MD, PhD; Patrick Sluss, MD, PhD; Elizabeth Lee-Lewandrowski, PhD, MPH; and Kent Lewandrowski, MD. The study was supported by a grant from Roche Diagnostics, which manufacturers the NT-proBNP assay studied.

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>